SIBION
DEAD

Serial Number

78975805

Owner

Sibion biosciences GmbH

Attorney

Beate Boudro, J.D.

Filing Date

Feb 7, 2003

Add to watchlist:

No watchlists yet
View on USPTO

SIBION Trademark

Serial Number: 78975805 • Registration: 2950387

SIBION is a trademark filed by Sibion biosciences GmbH on February 7, 2003. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Sibion biosciences GmbH (3 trademarks)

Karl-Heinz-Beckurts-Strasse 13
Julich 52428 , DE

Entity Type: 10

Trademark Details

Filing Date

February 7, 2003

Registration Date

May 10, 2005

Published for Opposition

March 23, 2004

Cancellation Date

December 16, 2011

Goods & Services

(Based on 44(e)) Electronic, electric, optical, chemical, biological and biochemical sensors for human, animal and plant material, for eucaryotic cells, for cells from microscopic small biopsies, for cells obtained from tissue samples, for cell culture lines, for chemically fixed tissues, for micrometastatic cells, for bone marrow cells, for body fluids, for stem cells, for cloned single cells and for differentiated stages from specific cells, namely, for biological, chemical, biochemical, biotechnological, medical and pharmaceutical research

Chemical and biological preparations, namely, extracts of cells and tissues and components thereof for scientific, research and industrial use; nucleic acids, peptides, proteins, cell lines for scientific purposes; diagnostic and analytic preparations for analysis and diagnosis for scientific purposes, namely, for the investigation and characterization of the molecular causes of diseases

(Based on 44(e)) Scientific and technological services, namely, diagnosis and analysis of animal and human diseases, cell differentiation of stem cells and other progenitor cells, steps in the development from micrometastatic cells to metastatic cells, characterization of the differentiated stages from specific cells, establishing of validated assay systems including cloning of target cDNA, transfection of target cDNA and implementation of biosensors, primary and secondary drug screening, selectivity screening against related targets, recording the kinetics of dose-response relations, determination of pharmacological parameters, identification of target structures for the development of medicaments, determination of the influence of various substances on the cell growth, proliferation, differentiation and secretion of molecules in various cell types, development of pharmaceuticals and medicaments, development of new technology for others in the fields of biology, chemistry, biochemistry, pharmacy, medicine, and biotechnology, licensing and research work in the fields of biomedicine and the search for pharmaceutically active agents

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 16, 2011 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2006 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2006 TCCA
REGISTERED-PRINCIPAL REGISTER
May 10, 2005 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Feb 15, 2005 REGV
ASSIGNED TO LIE
Feb 4, 2005 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 2, 2005 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 20, 2004 SUPC
DIVISIONAL PROCESSING COMPLETE
Dec 20, 2004 DPCC
USE AMENDMENT FILED
Dec 10, 2004 IUAF
DIVISIONAL REQUEST RECEIVED
Dec 10, 2004 DRRR
FAX RECEIVED
Dec 10, 2004 FAXX
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 15, 2004 NOAM
PUBLISHED FOR OPPOSITION
Mar 23, 2004 PUBO
NOTICE OF PUBLICATION
Mar 3, 2004 NPUB
FAX RECEIVED
Jan 20, 2004 FAXX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2004 CNSA
SEC. 44(D) CLAIM DELETED
Dec 18, 2003 44DD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2003 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2003 TROA
NON-FINAL ACTION MAILED
Aug 8, 2003 CNRT
ASSIGNED TO EXAMINER
Aug 7, 2003 DOCK
CASE FILE IN TICRS
Jul 21, 2003 CFIT
PAPER RECEIVED
Jun 30, 2003 MAIL